Company intelligence / Profile preview

Orbit One

Oxford, England, United Kingdomdiamondresortsandhotels.com ↗

Ownership: Private
Development stage: Other

Overview

Orbit Discovery provides high-throughput affinity and cell-based functional screening services using proprietary bead-based peptide display and microfluidic technologies. Their platform enables rapid identification of active peptides with agonist or antagonist properties against both soluble and membrane-bound targets, including GPCRs. The company collaborates with pharmaceutical and biotechnology partners to accelerate early-stage drug discovery programs. No direct clinical results reported as they are primarily a service/platform provider.

Modalities: PeptidesSmall moleculeBioconjugate
Industry: Drug Discovery Services

Partnerships

Oxford Sciences InnovationBorealis VenturesPerivoli Innovations

Beyond the preview

Go deeper on Orbit One.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbit One.

Explore the full profile